Hem/Onc Fellowship

Thank you for your interest in the Hematology/Medical Oncology Fellowship Program at the NewYork-Presbyterian Hospital/Weill Cornell Medical Center. 

Completion of this fully accredited three year combined subspecialty program leads to board eligibility in both Medical Oncology and Hematology. The division is comprised of approximately 100 full-time faculty members, who are involved in teaching and mentoring fellows. Five new fellows are matriculated each year.

Clinical Training

Clinical training is based at the NewYork-Presbyterian Hospital/Weill Cornell Medical Center, an 850 bed academic hospital on the Upper East Side of Manhattan. This institution serves as a community hospital for a large, diverse patient population, and also functions as a tertiary care referral center. Hematology and oncology ambulatory clinical areas are onsite at Weill Cornell Medical Center.

First Year of Fellowship Training

  • Entirely clinical 12 months mixed between inpatient and outpatient (ambulatory) care
  • Monthly rotations through five clinical services: Benign Hematology consult service; Solid tumor consult service; Bone Marrow Transplant (allo service), Bone Marrow Transplant (auto-service/CAR-T)/Myeloma, Leukemia, and Lymphoma

Second Year of Fellowship Training

  • Dedicated 18 months of research
  • 3 main tracks for research – Basic, Translational, and/or Clinical
  • Each fellow follows his or her interests and undertakes a research project under the mentorship and guidance of the division’s physician-scientists and clinical research faculty
  • Emphasis is placed on research design, methodology, and interpretation of data
  • Areas of active basic research by our faculty include angiogenesis, hematopoiesis, stem cell biology, immunology, vascular biology, viral oncogenesis, tumor biology, cellular adhesion mechanisms, gene regulation, molecular pathogenesis, AIDS virology, and cell signaling
  • Clinical research is facilitated via participation in a large multi-institutional cooperative group (Cancer and Leukemia Group B), and through institutional programs in leukemia, bone marrow/stem cell transplant, gene therapy, immunotherapy and novel chemotherapy. Our division has great strength in basic and translational science research. Thus, even fellows primarily interested in clinical research typically incorporate laboratory-based work into their research projects.
  • Fellows during the second year may also begin a two-year master's degree program in Clinical Investigation, a one-year certificate program in Clinical Investigation, and/or Principles in Clinical Research Methodology course.

Third Year of Fellowship Training

  • Comprised primarly of elective time, allowing each trainee to focus on specific areas of interest while consolidating their clinical and research knowledge and experience.
  • Six of the twelve months must be spent on clinical rotations; up to six months may be devoted to research.

Continuity Clinic

  • Throughout the three years of fellowship training, regardless of rotation or activity, each fellow participates in one half-day weekly Continuity Clinic, under the guidance and supervision of attending faculty, changing every six months.

Weekly Conferences

A full schedule of weekly conferences, didactic lectures, tumor boards and journal clubs rounds out the fellows’ educational activities. Attendance at some of these conferences is mandatory, and fellows are regularly called upon to present cases, present research findings or otherwise participate in discussions.

Monday Noon Conference 

  • Fellows-led Patient Case Review Conference
  • Interdisciplinary Basic and Clinical Science Interface Seminar
  • Fellows’ Clinic Case Conference
  • Professional Development - Leadership
  • Quality Improvement Series

Thursday Didactic Conference 

  • Hematology Core Curriculum Course
  • Fellows' Research in Progress Presentations (Fall/Spring)

Friday Didactic Conferences

  • Didactic conferences covering malignant hematology and oncology
  • Board review

Division-wide Conferences

  • Hematology and Oncology Grand Rounds
  • Coagulation Conference
  • Lymphoma Clinical Conference
  • Stem Cell Transplant Clinical Conference
  • Translational Science Journal Club

Weekly Multidisciplinary Tumor Boards

  • Breast Oncology Tumor Board
  • ENT Tumor Board
  • GI Tumor Board
  • GYN-Oncology Tumor Board
  • Hepatobiliary Tumor Board
  • Neuro-Oncology Tumor Board
  • Thoracic Oncology Tumor Board
  • Urologic Oncology Tumor Board
  • Thrombosis Board

Graduates of the division’s Fellowship Training Program are well prepared for research and/or clinical careers. Past graduates have gone on to become leaders in basic research, clinical research, and academia.

Hematology & Medical Oncology

Manuel Hidalgo, M.D., Chief

Hematology & Medical Oncology Fellowship

Christine Garcia, M.D., M.P.H., Program Director
Dr. Alexandra Arteaga Gomez, Assistant Program Director

Erica Marie Rucker, Fellowship Coordinator